单髁膝关节置换术后关节腔内注射皮质类固醇与假体周围关节感染风险
基于2015年1月至2020年10月全国行政索赔数据库的回顾性对照研究,共纳入47,903例单髁膝关节置换(UKA)患者,其中2,656例(5.5%)接受同侧关节腔内皮质类固醇注射(IACI)。IACI组假体周围关节感染(PJI)发生率为2.7%,对照组为1.3%,IACI组在6个月、1年和2年时PJI发生率均显著高于对照组(均P < .05),多数PJI(75%)发生于IACI后6个月内。作者认为IACI使UKA术后PJI风险翻倍,外科医生应知晓此风险以辅助决策。
要点
- UKA术后接受同侧IACI的患者PJI发生率为2.7%,未接受注射的对照组为1.3%。
- IACI组在6个月、1年和2年时PJI发生率均显著高于对照组(均P < .05)。
- 75%的PJI发生于IACI后6个月内,UKA至IACI的平均时间为355天。
核心结论
- 本研究中,UKA术后行IACI使PJI风险较未接受注射的患者翻倍。
- 作者认为外科医生应知晓这一增加的风险,以辅助其关于UKA关节腔注射的决策。
研究设计与样本
- 回顾性比较研究,证据等级III级。
- 对2015年1月至2020年10月的全国行政索赔数据库进行回顾性分析。
- 识别接受UKA并接受同侧IACI的患者,按2:1匹配至未接受IACI的原发UKA对照组。
- 采用多因素logistic分析评估6个月、1年和2年时PJI发生率的差异。
- 共识别47,903例病例,其中2,656例(5.5%)接受IACI。
主要发现
- UKA至IACI的平均时间为355天。
- IACI组PJI发生率为2.7%,对照组为1.3%。
- IACI组PJI发生率在6个月、1年和2年时均显著高于对照组(均P < .05)。
- 大多数PJI(75%)发生于IACI后前6个月内。
临床怎么用
- 作者认为外科医生应知晓UKA术后IACI与PJI风险增加相关,以辅助其决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative intra-articular joint injection is a known risk factor for developing prosthetic joint infection (PJI) in the immediate preoperative and postoperative periods for total knee arthroplasty, but is less defined in unicompartmental knee arthroplasty (UKA). The goal of this study was to elucidate the risk of developing PJI after intra-articular corticosteroid injection (IACI) into a post UKA knee. METHODS: A retrospective review of a nationwide administrative claims database was performed from January 2015 to October 2020. Patients who underwent UKA and had an ipsilateral IACI were identified and matched 2:1 to a control group of primary UKA patients who did not receive IACI. Multivariate logistic analyses were conducted to assess differences in PJI rates at 6 months, 1 year, and 2 years. RESULTS: A total of 47,903 cases were identified, of which 2,656 (5.5%) cases received IACI. The mean time from UKA to IACI was 355 days. The incidence of PJI in the IACI group was 2.7%, compared to 1.3% in the control group. The rate of PJI after IACI was significantly higher than the rate in the control group at 6 months, 1 year, and 2 years (all P < .05). The majority of PJI occurred within the first 6 months following IACI (75%). CONCLUSION: In this study, IACI in a UKA doubled the risk of PJI compared to patients who did not receive an injection. Surgeons should be aware of this increased risk to aid in their decision-making about injecting into a UKA. LEVEL OF EVIDENCE: III, retrospective comparative study.
引用
- Rodriguez HC, Mekkawy KL, Watkins A, et al. Risk of Periprosthetic Joint Infection After Intra-Articular Corticosteroid Injection Following Unicompartmental Knee Arthroplasty. J Arthroplasty. 2022. PMID: 36509243. doi:10.1016/j.arth.2022.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。